Status:

RECRUITING

Thrombin Generation and Prediction of Thromboembolic Events in Oncology Patients At Risk

Lead Sponsor:

Institut Cancerologie de l'Ouest

Collaborating Sponsors:

Diagnostica Stago

Conditions:

Solid Carcinoma

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Coagulation is a complex system which, through the action of thrombin, leads to the formation of fibrin, which stabilises the platelet clot. Any disturbance in the balance between procoagulant and ant...

Detailed Description

Biological blood samples will be taken specifically for research purposes. As far as possible and depending on the patient's schedule, a sample will be taken every month (during a consultation and/or ...

Eligibility Criteria

Inclusion

  • Patient aged \> 18 years,
  • Patient with a solid cancer at high risk of thrombosis, whether metastatic or not (lung, pancreatic, gastric or glioblastoma cancers)1,
  • Patients who have not received any systemic treatment for their cancer,
  • An informed patient who does not object to the use of data for research purposes and who has consented to the collection, use and storage of biological samples.

Exclusion

  • Patient who has had a VTE in the 12 months preceding the diagnosis of cancer,
  • Patient on low molecular weight heparins, standard unfractionated heparins and anti-vitamin K2,
  • Women who are pregnant, likely to become pregnant or who are breast-feeding,
  • Persons deprived of their liberty, under court protection, under curators or under the authority of a guardian,
  • Unable to undergo medical monitoring of the trial for geographical, social or psychological reasons.

Key Trial Info

Start Date :

September 12 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 1 2026

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT06051214

Start Date

September 12 2023

End Date

September 1 2026

Last Update

November 7 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Institut de Cancerologie de L'Ouest

Saint-Herblain, France, 44805